Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
- 31 March 2007
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 196 (3), 239.e1-239.e6
- https://doi.org/10.1016/j.ajog.2006.10.909
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2005
- Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2005
- Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of PreeclampsiaClinical Chemistry, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsiaObstetrics & Gynecology, 2003
- Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces ProteinuriaPublished by Elsevier BV ,2003
- Recent Insights into the Pathogenesis of Pre-eclampsiaPlacenta, 2002
- Preeclampsia: is there value in assessing before clinically evident disease?Obstetrics & Gynecology, 2001
- Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1999
- Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1997